CBBS's mission is to educate, develop, & inspire healthcare professionals in transfusion medicine and cellular therapy to improve practice and patient outcomes.
The early-bird discount AND the room block have been extended to Friday, April 26th, for the CBBS Annual Meeting in Palm Springs. Register today!!! https://t.co/NE9hW5p5eu https://t.co/NE9hW5p5eu
Early-bird discounted registration expires at 11:59 pm on Sunday! REGISTER NOW FOR THE CBBS ANNUAL MEETING!
https://t.co/LpLTg8JHrp https://t.co/LpLTg8JHrp
Online registration for the QSC Regional Seminar ends at 11:59 pm tomorrow!!! Register today by visiting: https://t.co/VsT1DHhHqO https://t.co/VsT1DHhHqO
REGISTER BEFORE THE EARLY BIRD RATE EXPIRES!!!!
✨Join us at the QSC Regional Seminar, March 30th in Oakland or Pomona. 🖱Click for more info! https://t.co/KyvQyFQX76
👏Thank you to our Exhibitors and Sponsors for helping make our Annual Meeting possible!!! 🌞🌴 To see who is joining us in Palm Springs visit: https://t.co/9jg6rq0y8T
🚨EXHIBITORS: It's not too late... https://t.co/9jg6rq0y8T
Researchers announced that an HIV-positive man who received a bone marrow transplant for Hodgkin lymphoma has remained virus-free more than a year after stopping antiretroviral drugs, according to a report in the journal Nature. https://t.co/9NNZ8ryHqx
The Broad Institute of MIT and Harvard is unveiling the Gerstner Center for Cancer Diagnostics at the Broad Institute, through which researchers will develop a biopsy procedure to detect and monitor cancer using a blood draw. https://t.co/qoijXcqXsq
A study in JAMA Pediatrics found that about 15% of 6,980 pediatric recipients of solid organ transplants were hospitalized with vaccine-preventable infections in the five years after surgery. https://t.co/6JzaYX4h8I
Analysis of thousands of individual cells in multiple myeloma patients allows for a much more precise diagnosis — distinguishing asymptomatic,... https://t.co/YnZoGRWOVO
CBBS ANNUAL MEETING REGISTRATION NOW OPEN!!! 🎉The Preliminary Schedule of Events is now posted! To register and for more info click the link below. https://t.co/WdubKXOkOa
Cellular Biomedicine has started the recruitment process for its early-stage study to be conducted in China that will evaluate its chimeric antigen... https://t.co/qkvchNhJ1l
Over the next three years, Orchard Therapeutics plans to file for U.S. and European regulatory approvals for three of its gene therapies and begin manufacturing its own products at the Fremont, CA, site it recently agreed to lease, president and CEO... https://t.co/aLd3fqQWbi